P
Primoz Petric
Researcher at University of Zurich
Publications - 34
Citations - 2177
Primoz Petric is an academic researcher from University of Zurich. The author has contributed to research in topics: Brachytherapy & Cervical cancer. The author has an hindex of 16, co-authored 26 publications receiving 1546 citations. Previous affiliations of Primoz Petric include Qatar Airways & Aarhus University Hospital.
Papers
More filters
Journal ArticleDOI
Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study.
Alina Sturdza,Richard Pötter,Lars Fokdal,Christine Haie-Meder,Li Tee Tan,Renaud Mazeron,Primoz Petric,Barbara Segedin,Ina M. Jürgenliemk-Schulz,C. Nomden,C. Gillham,Orla McArdle,Erik Van Limbergen,Hilde Janssen,Peter Hoskin,Gerry Lowe,Ekkasit Tharavichitkul,E. Villafranca,Umesh Mahantshetty,Petra Georg,Kathrin Kirchheiner,Christian Kirisits,Kari Tanderup,Jacob Christian Lindegaard +23 more
TL;DR: IGBT combined with radio-chemotherapy leads to excellent LC (91%), PC (87%), OS (74%), CSS (79%) with limited severe morbidity.
Journal ArticleDOI
Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy
Johannes Dimopoulos,Peter Petrow,Kari Tanderup,Primoz Petric,Daniel Berger,Christian Kirisits,Erik Morre Pedersen,Erik Van Limbergen,Christine Haie-Meder,Richard Pötter +9 more
TL;DR: To implement 3D image-based cervical cancer brachytherapy and to take advantage of its full potential, it is essential to successfully meet the MR imaging criteria described in the present recommendations of the GYN GEC-ESTRO working group.
Journal ArticleDOI
Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer.
Kari Tanderup,Lars Fokdal,Alina Sturdza,Christine Haie-Meder,Renaud Mazeron,Erik Van Limbergen,Ina M. Jürgenliemk-Schulz,Primoz Petric,Peter Hoskin,Wolfgang Dörr,Søren M. Bentzen,Christian Kirisits,Jacob Christian Lindegaard,Richard Pötter +13 more
TL;DR: Separate analyses according to stage of disease showed that dose to CTVHR, residual gross tumor volume (GTVres), and Intermediate Risk CTV (CTVIR) has significant impact on local control.
Journal ArticleDOI
The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results.
Johannes Dimopoulos,Christian Kirisits,Primoz Petric,Petra Georg,Stefan Lang,Daniel Berger,Richard Pötter +6 more
TL;DR: Preliminary clinical experience indicates that combined intracavitary and interstitial MRI-based brachytherapy in patients with significant residual disease after external-beam therapy extending up to the distal third of parametria is feasible and allows excellent local control and a low rate of morbidity.
Journal ArticleDOI
MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study
Richard Pötter,Kari Tanderup,Maximilian Schmid,Ina M. Jürgenliemk-Schulz,Christine Haie-Meder,Lars Fokdal,Alina Sturdza,Peter Hoskin,Peter Hoskin,Umesh Mahantshetty,Barbara Segedin,Kjersti Bruheim,Fleur Huang,Bhavana Rai,Rachel Cooper,Elzbieta van der Steen-Banasik,Erik Van Limbergen,Bradley R. Pieters,L.T. Tan,Remi A. Nout,Remi A. Nout,Astrid de Leeuw,Robin Ristl,Primoz Petric,Nicole Nesvacil,Kathrin Kirchheiner,Christian Kirisits,Jacob Christian Lindegaard,Cyrus Chargari,Isabelle Dumas,Gerry Lowe,Jamema Swamidas,Robert Hudej,Taran Paulsen Hellebust,Geetha Menon,Arun S Oinam,Peter Bownes,Melissa Christiaens,Marisol De Brabandere,Hilde Janssen,Bernard Oosterveld,Kees Koedooder,Anne Beate Langeland Marthinsen,Marit Sundset,Diane Whitney,Martijn Ketelaars,Ludy C.H.W. Lutgens,Brigitte Reinniers,Itxa Mora,E. Villafranca,Gergely Antal,Janaki Hadjiev,Francois Bachand,Deidre Batchelar,Beth Erickson,Jason Rownd,Geraldine Jacobson,Yusung Kim,Maarit Anttila,Jan-Erik Palmgren,Jusheng An,Marianne S. Assenholt,Susovan Banerjee,Søren M. Bentzen,Thomas Berger,Pittaya Dankulchai,Tamara Diendorfer,Ian Dilworth,Johannes Dimopoulos,Elke Dörr,Stefan Ecker,Mario Federico,Elena Fidarova,Israel Fortin,Petra Georg,Joanna Gora,Neamat Hegazy,Noha Jastaniyah,Nina Boje Kibsgaard Jensen,Thomas Liederer,Katarina Majercakova,Dragan Misimovic,Laura Motisi,Dina Najjari Jamal,Karen S. Nkiwane,Anders Schwartz-Vittrup,Monica Serban,Stéphanie Smet,Sofia Spampinato,Petra Trnkova,Margit Valgma,Henrike Westerveld,Joyce Siu Yu Wong,Kenji Yoshida +93 more
TL;DR: The EMBRACE-I study as mentioned in this paper evaluated local control and morbidity after chemoradiotherapy and MRI-based adaptive brachytherapy (IGABT) in locally advanced cervical cancer.